Erminia Ridolo, Francesco Pucciarini, Maria Cristina Nizi, Eleni Makri, Paola Kihlgren, Lorenzo Panella, & Cristoforo Incorvaia. (2020). Mabs for treating asthma: Omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab. Taylor & Francis Group.
Chicago Style (17th ed.) CitationErminia Ridolo, Francesco Pucciarini, Maria Cristina Nizi, Eleni Makri, Paola Kihlgren, Lorenzo Panella, and Cristoforo Incorvaia. Mabs for Treating Asthma: Omalizumab, Mepolizumab, Reslizumab, Benralizumab, Dupilumab. Taylor & Francis Group, 2020.
MLA (9th ed.) CitationErminia Ridolo, et al. Mabs for Treating Asthma: Omalizumab, Mepolizumab, Reslizumab, Benralizumab, Dupilumab. Taylor & Francis Group, 2020.
Warning: These citations may not always be 100% accurate.